CalciMedica (CALC) vs Optimi Health (OPTH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
CalciMedica is the larger company by market cap ($8.7 million vs $8.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CALC | OPTH |
|---|---|---|
| Share price | $1.26 | $1.51 |
| Market cap | $8.69M | $8.65M |
| 1-day change | +7.69% | -13.71% |
| YTD return | -96.18% | — |
| 1-year return | -92.34% | — |
| EPS (TTM) | $-4.41 | $-1.56 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-29.56M | — |
| 52-week high | $36.00 | $6.40 |
| 52-week low | $1.00 | $1.51 |
| Distance from 52-week high | -96.50% | -76.41% |
| Analyst consensus | none | — |
| Avg. price target upside | +3868.25% | — |
| Average volume | 80.15K | 43.55K |
| Shares outstanding | 6.90M | 5.73M |
| Employees | 15 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About CalciMedica
CALC stock →CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia.
Health Care · Biotechnology: Pharmaceutical Preparations · 15 employees
About Optimi Health
OPTH stock →Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.
Health Care · Biotechnology: Pharmaceutical Preparations
CALC vs OPTH FAQ
Which is bigger, CalciMedica or Optimi Health?
CalciMedica (CALC) is larger, with a market capitalization of $8.69M compared with $8.65M for Optimi Health (OPTH).
Are CalciMedica and Optimi Health in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.